Toggle navigation
Home
Search
Services
Blog
Contact
About
Produce Rodent Monoclonal Antibodies to Htlv III/Lav
Hwang, Kou M.
Genelabs Technologies, Inc., Redwood City, CA, United States
Search 5 grants from Kou Hwang
Search grants from Genelabs Technologies, Inc.
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Using Cognitive Neuroscience to Predict Dyslexia among Kindergarden Children
Reverse Genetics with A Coronavirus Infectious Construct
Minority Predoctoral Fellowship Program
Phase I Trials of Anti-Transferrin Receptor Antibodies
Cooperative Group Outreach Program
Recently added grants:
Anti-Atherogenic Mechanisms of Drebrin
Mechanisms of glycine-based therapy for atherosclerosis
Cellular and molecular mechanisms of diabetic atherosclerosis
Functional Genomics of Cardiac Sodium Channel Variants
A molecular and functional dissection of the vagal heart-to-brain physiological circuits
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
Division of Cancer Epidemiology And Genetics (NCI)
Type
Small Business Innovation Research – Phase I (N43)
Project #
N43CP061054-001
Application #
3632220
Study Section
Project Start
1986-09-01
Project End
Budget Start
1986-09-11
Budget End
1987-02-28
Support Year
Fiscal Year
1986
Total Cost
Indirect Cost
Institution
Name
Genelabs Technologies, Inc.
Department
Type
DUNS #
City
Redwood City
State
CA
Country
United States
Zip Code
94063
Related projects
NIH 1986
N43 CP
Produce Rodent Monoclonal Antibodies to Htlv III/Lav
Hwang, Kou M. / Genelabs Technologies, Inc.
NIH 1986
N43 CP
Produce Rodent Monoclonal Antibodies to Htlv III/Lav
Hwang, Kou M. / Genelabs Technologies, Inc.
Comments
Be the first to comment on this grant